One important change is that they state, GLP-1 RA therapy may be continued preoperatively in patients without elevated risk of delayed gastric emptying. The risk factors they state include: escalation phase of dosing, higher dose, weekly dosing (as opposed to daily dosing), gastrointestinal symptoms (nausea, vomiting, abdominal pain, dyspepsia, constipation), and medical conditions that may cause delayed gastric emptying
Deb SK, Gough LA, Sparks SA, et al
Its ideal for those who want a filling yet low-carb option without heaviness
Vistra Gluta Complex 800Mg vs Other Glutathione Supplements Many glutathione products are on the market
There is no one-size-fits-all answer
In the long-term, Dr